Patel HJ, Patel JS Patel KN. Clinical study of hepatoprotective drug Phyllanthus amarus. Research Journal of Pharmaceutical Biological and Chemical Sciences. Research Journal of Pharmaceutical Biological and Chemical Sciences 2010;335-340.
Pramyothin, P., Ngamtin, C., Poungshompoo, S., and Chaichantipyuth, C. Hepatoprotective activity of Phyllanthus amarus Schum. et. Thonn. extract in ethanol treated rats: in vitro and in vivo studies. J Ethnopharmacol. 11-1-2007;114(2):169-173. View abstract.
Rajeshkumar, N. V. and Kuttan, R. Phyllanthus amarus extract administration increases the life span of rats with hepatocellular carcinoma. J Ethnopharmacol. 2000;73(1-2):215-219. View abstract.
Rajeshkumar, N. V., Joy, K. L., Kuttan, G., Ramsewak, R. S., Nair, M. G., and Kuttan, R. Antitumour and anticarcinogenic activity of Phyllanthus amarus extract. J Ethnopharmacol. 2002;81(1):17-22. View abstract.
Rao, M. V. and Alice, K. M. Contraceptive effects of Phyllanthus amarus in female mice. Phytother.Res 2001;15(3):265-267. View abstract.
Raphael, K. R. and Kuttan, R. Inhibition of experimental gastric lesion and inflammation by Phyllanthus amarus extract. J Ethnopharmacol. 2003;87(2-3):193-197. View abstract.
Raphael, K. R., Sabu, M. C., and Kuttan, R. Hypoglycemic effect of methanol extract of Phyllanthus amarus Schum & Thonn on alloxan induced diabetes mellitus in rats and its relation with antioxidant potential. Indian J Exp.Biol. 2002;40(8):905-909. View abstract.
Raphael, K. R., Sabu, M., Kumar, K. H., and Kuttan, R. Inhibition of N-Methyl N'-nitro-N-nitrosoguanidine (MNNG) induced gastric carcinogenesis by Phyllanthus amarus extract. Asian Pac.J Cancer Prev. 2006;7(2):299-302. View abstract.
Ravikumar, Y. S., Ray, U., Nandhitha, M., Perween, A., Raja, Naika H., Khanna, N., and Das, S. Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source. Virus Res 2011;158(1-2):89-97. View abstract.
Sane RT, Kuber VV Chalissery MS et al. Hepatoprotection by Phyllanthus amarus and Phyllanthus debilis in CCl4-induced liver dysfunction. Current Science 1995;68(12):1243-1246.
Sarkar MK, Kinter M Mazumder B et al. Purification and characterisation of a novel antioxidant protein molecule from Phyllanthus niruri. Food Chemistry 2009;1405-1412.
Sharma, P., Parmar, J., Verma, P., and Goyal, P. K. Modulatory influence of Phyllanthus niruri on oxidative stress, antioxidant defense and chemically induced skin tumors. J Environ.Pathol.Toxicol.Oncol. 2011;30(1):43-53. View abstract.
Sharma, P., Parmar, J., Verma, P., Sharma, P., and Goyal, P. K. Anti-tumor activity of Phyllanthus niruri (a medicinal plant) on chemical-induced skin carcinogenesis in mice. Asian Pac.J Cancer Prev. 2009;10(6):1089-1094. View abstract.
Singh B, Agrawal PK Thakur RS. A new lignan and a new neolignan from Phyllanthus niruri. Journal of Natural Products 1989;48-51.
Subeki, S., Matsuura, H., Takahashi, K., Yamasaki, M., Yamato, O., Maede, Y., Katakura, K., Kobayashi, S., Trimurningsih, T., Chairul, C., and Yoshihara, T. Anti-babesial and anti-plasmodial compounds from Phyllanthus niruri. J Nat.Prod. 2005;68(4):537-539. View abstract.
Syamasundar, K. V., Singh, B., Thakur, R. S., Husain, A., Kiso, Y., and Hikino, H. Antihepatotoxic principles of Phyllanthus niruri herbs. J Ethnopharmacol. 1985;14(1):41-44. View abstract.
Tamil, I. G., Dineshkumar, B., Nandhakumar, M., Senthilkumar, M., and Mitra, A. In vitro study on alpha-amylase inhibitory activity of an Indian medicinal plant, Phyllanthus amarus. Indian J Pharmacol. 2010;42(5):280-282. View abstract.
Thamlikitkul, V., Wasuwat, S., and Kanchanapee, P. Efficacy of Phyllanthus amarus for eradication of hepatitis B virus in chronic carriers. J Med Assoc.Thai. 1991;74(9):381-385. View abstract.
Thyagarajan, S. P., Jayaram, S., Valliammai, T., Madanagopalan, N., Pal, V. G., and Jayaraman, K. Phyllanthus amarus and hepatitis B. Lancet 10-13-1990;336(8720):949-950. View abstract.
Thyagarajan, S. P., Subramanian, S., Thirunalasundari, T., Venkateswaran, P. S., and Blumberg, B. S. Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus. Lancet 10-1-1988;2(8614):764-766. View abstract.
Thyagarajan, S. P., Thiruneelakantan, K., Subramanian, S., and Sundaravelu, T. In vitro inactivation of HBsAg by Eclipta alba Hassk and Phyllanthus niruri Linn. Indian J Med Res 1982;76 Suppl:124-130. View abstract.
Tona, L., Mesia, K., Ngimbi, N. P., Chrimwami, B., Okond'ahoka, Cimanga, K., De, Bruyne T., Apers, S., Hermans, N., Totte, J., Pieters, L., and Vlietinck, A. J. In-vivo antimalarial activity of Cassia occidentalis, Morinda morindoides and Phyllanthus niruri. Ann.Trop.Med Parasitol. 2001;95(1):47-57. View abstract.
Udupa AL, Sanjeeva Benegal A. Diuretic activity of Phyllanthus niruri (Linn.) in rats. Health 2010;511-512.
Venkateswaran, P. S., Millman, I., and Blumberg, B. S. Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies. Proc.Natl.Acad.Sci U.S.A 1987;84(1):274-278. View abstract.
Vijayanand V, Nagarajan B Vasu K. Efficacy of Azadirachta indica and Phyllanthus amarus in experimental hepatitis in dogs. Indian Journal of Veterinary Medicine 2007;25-28.
Wongnawa M, Thaina P Bumrungwong N et al. Effect of Phyllanthus amarus Schum. and Thonn. and its protective mechanism on paracetamol hepatotoxicity in rats. Traditional Medicine and Nutraceuticals, A proceedings of WOCMAP III: The Third World Congress on Medicinal and Aromatic Plants 2003;
Woottisin, S., Hossain, R. Z., Yachantha, C., Sriboonlue, P., Ogawa, Y., and Saito, S. Effects of Orthosiphon grandiflorus, Hibiscus sabdariffa and Phyllanthus amarus extracts on risk factors for urinary calcium oxalate stones in rats. J Urol. 2011;185(1):323-328. View abstract.
Xin-Hua, W., Chang-Qing, L., Xing-Bo, G., and Lin-Chun, F. A comparative study of Phyllanthus amarus compound and interferon in the treatment of chronic viral hepatitis B. Southeast Asian J Trop.Med Public Health 2001;32(1):140-142. View abstract.
Yeh, S. F., Hong, C. Y., Huang, Y. L., Liu, T. Y., Choo, K. B., and Chou, C. K. Effect of an extract from Phyllanthus amarus on hepatitis B surface antigen gene expression in human hepatoma cells. Antiviral Res 1993;20(3):185-192. View abstract.
Zhang JL, He WN Ye P. Clinic observation on Phyllanthus amarus for treating chronic HBV infection. Chinese Journal of Integrated Traditional & Western Medicine on Liver Diseases 1992;8-10.
Zhu FM, Zhang JQ Zhang XZ et al. Observation on the effect of fujian's Phyllanthus amarus in treatment of HBV infection. Chinese Journal of Integrated Traditional & Western Medicine on Liver Diseases 1992;10-11.
Abu Hassan MR, Hj Md Said R, Zainuddin Z, et al. Effects of one-year supplementation with Phyllanthus niruri on fibrosis score and metabolic markers in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. Heliyon 2023;9(6):e16652. View abstract.
Agri Res Svc: Dr. Duke's phytochemical and ethnobotanical databases. www.ars-grin.gov/duke (Accessed 3 November 1999).
Araújo RF Jr, Soares LA, da Costa Porto CR, et al. Growth inhibitory effects of Phyllanthus niruri extracts in combination with cisplatin on cancer cell lines. World J Gastroenterol. 2012;18(31):4162-6168. View abstract.
Bagheri, H., Bompart, G., Girolami, J. P., Montastruc, J. L., and Montastruc, P. Is yohimbine-induced increase in salivary secretion a kinin-dependent mechanism? Fundam.Clin Pharmacol 1992;6(1):17-20. View abstract.
Cameron, O. G., Zubieta, J. K., Grunhaus, L., and Minoshima, S. Effects of yohimbine on cerebral blood flow, symptoms, and physiological functions in humans. Psychosom.Med 2000;62(4):549-559. View abstract.
Charney, D. S., Heninger, G. R., and Redmond, D. E., Jr. Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sci. 7-4-1983;33(1):19-29. View abstract.
Charney, D. S., Heninger, G. R., and Sternberg, D. E. Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine. Life Sci 6-7-1982;30(23):2033-2041. View abstract.
Charney, D. S., Price, L. H., and Heninger, G. R. Desipramine-yohimbine combination treatment of refractory depression. Implications for the beta-adrenergic receptor hypothesis of antidepressant action. Arch.Gen.Psychiatry 1986;43(12):1155-1161. View abstract.
Chatelut, E., Rispail, Y., Berlan, M., and Montastruc, J. L. Yohimbine increases human salivary secretion. Br.J Clin Pharmacol. 1989;28(3):366-368. View abstract.
Cimolai, N. and Cimolai, T. Yohimbine use for physical enhancement and its potential toxicity. J Diet.Suppl 2011;8(4):346-354. View abstract.
Giampreti, A., Lonati, D., Locatelli, C., Rocchi, L., and Campailla, M. T. Acute neurotoxicity after yohimbine ingestion by a body builder. Clin Toxicol.(Phila) 2009;47(8):827-829. View abstract.
Gurguis, G. N., Vitton, B. J., and Uhde, T. W. Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls. Psychiatry Res. 6-16-1997;71(1):27-39. View abstract.
Knoll, L. D., Benson, R. C., Jr., Bilhartz, D. L., Minich, P. J., and Furlow, W. L. A randomized crossover study using yohimbine and isoxsuprine versus pentoxifylline in the management of vasculogenic impotence. J Urol. 1996;155(1):144-146. View abstract.
Landis, E. and Shore, E. Yohimbine-induced bronchospasm. Chest 1989;96(6):1424. View abstract.
Mann, K., Klingler, T., Noe, S., Roschke, J., Muller, S., and Benkert, O. Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction. Arch.Sex Behav. 1996;25(1):1-16. View abstract.
Montastruc, P., Berlan, M., and Montastruc, J. L. Effects of yohimbine on submaxillary salivation in dogs. Br J Pharmacol 1989;98(1):101-104. View abstract.
Morgan, C. A., III, Southwick, S. M., Grillon, C., Davis, M., Krystal, J. H., and Charney, D. S. Yohimbine-facilitated acoustic startle reflex in humans. Psychopharmacology (Berl) 1993;110(3):342-346. View abstract.
Mustonen, P., Savola, J., and Lassila, R. Atipamezole, an imidazoline-type alpha(2)-adrenoceptor inhibitor, binds to human platelets and inhibits their adrenaline-induced aggregation more effectively than yohimbine. Thromb.Res 8-1-2000;99(3):231-237. View abstract.
Myers, A. and Barrueto, F., Jr. Refractory priapism associated with ingestion of yohimbe extract. J Med Toxicol. 2009;5(4):223-225. View abstract.
Riley AJ, Goodman R, Kellett JM, and et al. Double blind trial of yohimbine hydrochloride in the treatment of erection inadequacy. Sexual Marital Ther 1989;4(1):17-26.
Rowland, D. L., Kallan, K., and Slob, A. K. Yohimbine, erectile capacity, and sexual response in men. Arch Sex Behav 1997;26(1):49-62. View abstract.
Susset, J. G., Tessier, C. D., Wincze, J., Bansal, S., Malhotra, C., and Schwacha, M. G. Effect of yohimbine hydrochloride on erectile impotence: a double-blind study. J Urol. 1989;141(6):1360-1363. View abstract.
Bharucha AE, Skaar T, Andrews CN, et al Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjects. Neurogastroenterol Motil. 2008;20(8):891-9. View abstract.
Foster S, Tyler VE. Tyler's Honest Herbal, 4th ed., Binghamton, NY: Haworth Herbal Press, 1999.
Hollander E, McCarley A. Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers. J Clin Psychiatry 1992;53:207-9. View abstract.
Jacobsen FM. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry 1992;53:119-22. View abstract.
Kearney T, Tu N, Haller C. Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases. Ann Pharmacother 2010;44:1022-9. View abstract.
Le Corre P, Parmer RJ, Kailasam MT, et al. Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism. Clin Pharmacol Ther. 2004;76(2):139-53. View abstract.
Lobay D. Rauwolfia in the Treatment of Hypertension. Integr Med (Encinitas). 2015 Jun;14(3):40-6. View abstract.
Mueller-Schoell A, Michelet R, Weinelt F, Kloft C, Mikus G. CYP2D6 phenotype explains reported yohimbine concentrations in four severe acute intoxications. Arch Toxicol. 2021. View abstract.
Sheldon MB, Kotte JH. Effect of Rauwolfia serpentina and reserpine on the blood pressure in essential hypertension; a long-term double-blind study. Circulation. 1957 Aug;16(2):200-6. View abstract.
Sklar S, et al. Drug therapy screening system. Indianapolis, IN: First Data Bank 99.1-99. 2 eds.
Teloken C, Rhoden EL, Sogari P, et al. Therapeutic effects of high dose yohimbine hydrochloride on organic erectile dysfunction. J Urol 1998;159:122-4. View abstract.
VandenBrink, B. M., Foti, R. S., Rock, D. A., Wienkers, L. C., and Wahlstrom, J. L. Prediction of CYP2D6 drug interactions from in vitro data: evidence for substrate-dependent inhibition. Drug Metab Dispos. 2012;40(1):47-53. View abstract.
Select a condition to view a list of vitamins
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.